Insider · CIK 0001604458

Bronstein Ben

Reports to the SEC for 1 company · LEXINGTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001604458

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,977 sh	—	—	4,977
2026-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+70K sh	—	—	70,000
2026-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,309 sh	—	—	5,309
2025-06-10	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+62.7K sh	—	—	62,728
2025-06-10	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,619 sh	—	—	3,619
2024-06-10	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,860 sh	—	—	3,860
2024-06-04	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+40.3K sh	—	—	40,282
2024-06-04	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,604 sh	—	—	2,604
2024-06-04	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,778 sh	—	—	2,778
2023-06-30	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,372 sh	—	—	1,372
2023-06-30	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.2K sh	—	—	21,222
2023-06-30	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,464 sh	—	—	1,464
2023-06-27	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+9,604 sh	—	—	0
2023-06-27	ALDXAldeyra Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+9,604 sh	$0.55	+$5,301.408	28,248
2022-06-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,711 sh	—	—	3,711
2022-06-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+53.8K sh	—	—	53,812
2022-06-07	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,479 sh	—	—	3,479
2021-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+933 sh	—	—	933
2021-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+875 sh	—	—	875
2021-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.5K sh	—	—	13,534
2020-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,311 sh	—	—	2,311
2020-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,541 sh	—	—	1,541
2020-06-09	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26.5K sh	—	—	26,503
2019-09-17	ALDXAldeyra Therapeutics, Inc.P Purchase	Director	PPurchase	+1,700 sh	$5.85	+$9,945	18,644
2019-06-04	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+1,102 sh	—	—	1,102
2019-06-04	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	18,951
2019-06-04	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+1,653 sh	—	—	1,653
2018-06-07	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+903 sh	—	—	903
2018-06-07	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+1,354 sh	—	—	1,354
2018-06-07	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,526
2017-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+1,481 sh	—	—	1,481
2017-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+2,222 sh	—	—	2,222
2017-06-08	ALDXAldeyra Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+17.8K sh	—	—	17,776
2017-02-17	ALDXAldeyra Therapeutics, Inc.P Purchase	Director	PPurchase	+4,444 sh	$4.50	+$20K	16,944
2016-06-09	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+6,083 sh	—	—	6,083
2015-06-09	ALDXAldeyra Therapeutics, Inc. · Employee Stock Option (Right to Buy)A Award	Director	AAward	+6,083 sh	—	—	6,083

Recent filings

Accepted (ET)
Jun 114
Bronstein Ben0001193125-26-267600
SEC(opens sec.gov)
Jun 124
Bronstein Ben0000950170-25-085454
SEC(opens sec.gov)
Jun 64
Bronstein Ben0000950170-24-069885
SEC(opens sec.gov)
Jul 54
Bronstein Ben0000950170-23-031781
SEC(opens sec.gov)
Jun 294
Bronstein Ben0000899243-23-016709
SEC(opens sec.gov)
Jun 94
Bronstein Ben0000899243-22-021632
SEC(opens sec.gov)
Jun 104
Bronstein Ben0000899243-21-023007
SEC(opens sec.gov)

Companies

Aldeyra Therapeutics, Inc.DirectorALDX

Address

C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE

LEXINGTON, MA, 02421